samedan logo

 
 
spacer
home > news
INDUSTRY NEWS AND PRESS RELEASES

World-class multidisciplinary partnership to take science one step closer to building fully functional organs at lightning speed

In the European project ENLIGHT, researchers from academic centers and leading industries across Europe are joining forces to develop a living model of the pancreas to enable better testing of diabetes medication. More>>

 
phone +31 499 364100
email Gelatin@rousselot.com
web www.rousselot.com
email Rousselot BV, Kanaaldijk Noord 20 5691 NM SON
 

SPT Labtech acquires BioMicroLab

Deal strategically expands SPT Labtech’s offering in sample management for life sciences

SPT Labtech, a global leader in the design and development of automated instrumentation and consumables for life science applications, announces the acquisition of BioMicroLab, a robotics automation provider for life science laboratories. More>>

 
phone +44 (0)1223 627555
email discover@sptlabtech.com
web www.sptlabtech.com
email SPT Labtech Ltd. Melbourn Science Park Melbourn Hertfordshire SG8 6HB United Kingdom
 

NovalGen Enters Strategic Partnership with HALIX B.V. to Manufacture Clinical Trial Materials

NovalGen Ltd. (“NovalGen”), a biopharmaceutical company developing breakthrough cancer therapies and HALIX B.V. (“HALIX”), a contract development and manufacturing organisation, today announced a strategic partnership. Within the scope of this partnership, HALIX will provide manufacturing of clinical supply of NovalGen’s therapies. More>>

 
phone +44(0207) 431 7976
email info@novalgen.co.uk
web www.novalgen.com
email NovalGen Ltd Argyle House Joel Street Northwood Hills HA6 1NW, UK
 

Catalent Announces Commercial Supply Agreement with Aurinia Pharmaceuticals for Newly-Approved LUPKYNIST Softgels

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it recently signed a multi-year commercial supply agreement with Aurinia Pharmaceuticals. More>>

 
phone +1 888 765 8846
email info@catalent.com
web www.catalent.com
email 14 Schoolhouse Road, Somerset 08873 NJ , USA
 

PTC Therapeutics Reports the Initiation of the Second Stage of the FITE19 Phase 2/3 Clinical Trial Evaluating PTC299 for the Treatment of COVID-19

PTC Therapeutics, Inc. (NASDAQ: PTCT), today announced the initiation of the second stage of the FITE19 clinical trial to assess PTC299 in COVID-19 patients. PTC299 is an oral investigational drug with a novel dual mechanism of action that has the potential to inhibit viral replication and attenuate the uncontrolled inflammatory response that ensues after infection. More>>

 
phone 908 222 7000
email info@ptcbio.com
web www.ptcbio.com
email PTC Therapeutics Inc. 100 Corporate Court South Plainfield, NJ 07080-2449
 

Theravectys Announces $20M Funding Round

Funding to drive Phase 1 and 1-2 Clinical Trials for COVID-19, HPV induced cancers and HBV Vaccine Candidates

THERAVECTYS, the world leading pioneer in lentiviral vector technology, announced today a fully subscribed $20M funding round. This funding will be used to progress the Theravectys pipeline by driving several vaccine candidates, including their COVID vaccine, into phase 1 and 1-2 clinical trials. More>>

 
email info@theravectys.com
web www.theravectys.com
 

Vetter continues its successful performance at the 2021 CMO Leadership Awards

Ravensburg, Germany, February 18, 2021 – Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), was granted the 2021 CMO Leadership Awards in five core categories – quality, expertise, compatibility, capabilities, and service. The award, now in its tenth year, was given by the leading trade press publication, Life Science Leader. Vetter was also the recipient of the award in a variety of categories in previous years. More>>

 
phone +49 751 3700 0
email info@vetter-pharma.com
web www.vetter-pharma.com
email Eywiesenstraße 5, 88212 Ravensburg, Germany
 

Sonoco ThermoSafe Celebrates First Pegasus ULD® Uplift on AirBridgeCargo Airlines, Releases Case Study

ARLINGTON HEIGHTS, Ill., Feb. 08, 2021 -- Sonoco ThermoSafe, a unit of Sonoco (NYSE:SON) and the leading global provider of temperature assurance packaging for life sciences and healthcare, and AirBridgeCargo Airlines, an all-cargo carrier within the Volga-Dnepr Group, have successfully conducted a test shipment with ThermoSafe’s new Pegasus ULD®, the world’s first passive bulk temperature controlled container for pharmaceutical use that is an approved unit load device. More>>

 
phone 843-383-7000
web https://www.sonoco.com/
email 1 North 2nd St. Hartsville, South Carolina 29550
 

Aptar’s Activ-Film™ Technology Selected to Protect New SARS Rapid Antigen Test for COVID-19 Diagnosis

Crystal Lake, Illinois, February 16, 2021 - AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, announced that its Activ-Film™ technology was selected to protect a new SARS Rapid Antigen test for COVID-19 that recently received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). More>>

 
phone +33 (0)13 917 2020
email info.pharma@aptar.com
web www.aptar.com/pharma
email 36-38 Rue de la Princesse, 78431 Louveciennes
 

Medidata Launches Sensor Cloud, Ushering in Next Generation Solution for Connected Devices and Wearable Sensors in Clinical Trials

Unified solution simplifies and expedites sensor integration, data ingestion and analysis, and digital biomarker discovery New technology will generate intelligent insights and help improve clinical outcomes More>>

 
web www.medidata.com/en
 
spacer
News and Press Releases

CureVac and Bayer join forces on COVID-19 vaccine candidate CVnCoV

Companies enter into a collaboration and services agreement / Bayer to support CureVac in numerous areas, including development and supply of CVnCoV / CureVac benefits from Bayer´s expertise and established infrastructure / Plan to facilitate the supply of several hundred million doses
More info >>


White Papers

Inhaler Adherence: Exploring Key Factors

Aptar Pharma

Aptar Pharma recently hosted an expert panel roundtable on “Inhaler Adherence”. This international scientific forum was held in Paris, France on November 29th 2013. The roundtable was organized to explore and exchange views on the issues which may influence inhaler adherence/ compliance with a particular focus on asthma and C.O.P.D. therapies and their corresponding inhaler devices (MDIs, DPIs).
More info >>

Industry Events

DIA Europe 2021

15-19 March 2021, VIRTUAL CONFERENCE

DIA Europe is the must-attend event for all life science professionals working in drug development, from discovery to marketed use. It encourages open collaboration by bringing together representatives from the entire spectrum of the life science landscape and facilitating crucial discussions across several topic tracks: Clinical Development, Regulatory Strategy, Pharmacovigilance, Value and Access, Health Policy, and many more.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement